A Rare Opportunity to Acquire a Mission-Ready U.S. Sterile Manufacturing Platform with a Proven Track Record in Complex, High-Margin Products

A Compelling Opportunity to Acquire a Differentiated, Sterile & Non-Sterile Drug Delivery Platform

​

Opportunity to acquire a scaled, FDA-compliant pharmaceutical manufacturing campus with diversified dosage forms, excess capacity, and integrated CDMO capabilities​​​​​​

Compelling opportunity to acquire or lease a turnkey, FDA-ready aseptic fill-finish manufacturing facility with expansion capacity and strategic U.S. access.​